Covestor’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
19
-12
-39% -$299 ﹤0.01% 2680
2026
Q2
$1K Buy
31
+22
+244% +$375 ﹤0.01% 2251
2026
Q1
$0 Hold
9
– – ﹤0.01% 2613
2025
Q4
$0 Hold
9
– – ﹤0.01% 2588
2025
Q3
$0 Hold
9
– – ﹤0.01% 2601
2025
Q2
$0 Buy
9
+4
+80% +$43 ﹤0.01% 2573
2025
Q1
$0 Hold
5
– – ﹤0.01% 2566
2024
Q4
$0 Hold
5
– – ﹤0.01% 2574
2024
Q3
$0 Sell
5
-2
-29% -$45 ﹤0.01% 2571
2024
Q2
$0 Buy
+7
New +$109 ﹤0.01% 2584
2022
Q2
– Sell
-13
Closed – – 2205
2022
Q1
$0 Buy
13
+2
+18% +$36 ﹤0.01% 2320
2021
Q4
$0 Buy
+11
New +$333 ﹤0.01% 2231

Other funds holding NRIX

Covestor's NRIX Position: Q3 2026 in Review

Covestor reduced its Nurix Therapeutics (NRIX) stake by 39% in Q3 2026, selling an estimated $299 and leaving 19 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2680.

Covestor first reported a position in NRIX in Q4 2021 and has held it in 12 quarters since. The position peaked at $1K in Q2 2026. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Covestor held 19 shares of Nurix Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 12 Nurix Therapeutics shares in Q3 2026, an estimated $299.
  • Nurix Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2680 holding.
  • Covestor first reported a position in Nurix Therapeutics in Q4 2021 and has held it in 12 quarters since.
  • Covestor's Nurix Therapeutics position peaked at $1K in Q2 2026.
  • 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.